MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Impact of dopamine replacement therapy on shame in Parkinson’s disease patients

    S. Catalano Chiuvé, D. Benis, A. Zulet, P. Krack, V. Fleury (Geneva, Switzerland)

    Objective: This study aims to investigate the effect of dopaminergic replacement therapy (DRT) on shame using emotional dynamic rating scales during ON and OFF-DRT states.…
  • 2023 International Congress

    Identifying neural biomarkers of motivated behavior in Parkinson’s disease using sensing-capable DBS devices

    N. Provenza, S. Rajesh, N. Diab, S. Reddy, B. Lamichhane, A. Sabharwal, J. Herron, Y. Gazes, C. Le Heron, S. Sheth, N. Vanegas-Arroyave (Houston, USA)

    Objective: To investigate neural correlates of motivated, goal directed behavior within the basal ganglia. Background: Apathy is a common and debilitating complication of Parkinson’s disease…
  • 2023 International Congress

    Can radiofrequency lesion be better than DBS?

    J. Brainer, P. Brainer, A. Brainer, P. Brainer (Recife, Brazil)

    Objective: Pallidotomy represents a viable alternative for Parkinson disease(PD) symptoms treatment and has several important advantages, including a decreased need for access to specialists and clinical follow-up, improved affordability, and a lower infection risk, producing high long-term success rates and low morbidity rates. Background: Pallidotomy is recognized as effective for treating the symptoms of Parkinson's disease. Sometimes, radiofrequency may…
  • 2023 International Congress

    Predicting clinical response after Gamma Knife thalamotomy in essential tremor

    R. Barriol, G. Carey, G. Touzet, L. Defebvre, N. Carrière (Lille, France)

    Objective: To determine clinical, surgical and radiological factors associated with tremor reduction after Gamma Knife thalamotomy (GKT) for essential tremor (ET). Background: GKT is a…
  • 2023 International Congress

    Subtyping Parkinson’s disease: Quality of life changes after subthalamic stimulation depend on nonmotor and motor symptoms

    L. Braun, S. Jost, P. Loehrer, A. Sauerbier, K. Ashkan, A. Rizos, M. Santos Ghilardi, A. Gronostay, J. Evans, M. Silverdale, R. Cury, E. Fonoff, G. Fink, A. Antonini, C. Nimsky, K. Chaudhuri, L. Timmermann, V. Visser-Vandewalle, P. Martinez-Martin, H. Dafsari (Cologne, Germany)

    Objective: To investigate if patients with Parkinson’s disease (PD) undergoing subthalamic stimulation (STN-DBS) can be clustered in different subtypes based on demographic, motor and non-motor…
  • 2023 International Congress

    Examining the Correlation Between Multi-Spectral Diffusion Weighted Imaging Quantitative Maps and Unified Parkinson’s Disease Rating Scale Scores

    I. Shelley, I. Ailes, M. Syed, K. Shivok, J. Miao, L. Krisa, F. Mohamed, R. Sergott, T. Liang, A. Sharan, M. Kogan, C. Wu, M. Alizadeh (Philadelphia, USA)

    Objective: We aimed to correlate Unified Parkinson’s Disease Rating Scale (UPDRS) scores with quantitative maps to determine the ability to generate non-invasive biomarkers for Parkinson’s…
  • 2023 International Congress

    Impulse Control Disorder and medication management in Patients with Early-Onset Parkinson’s Disease

    J. Jacobson, K. Ghoniem, A. Mullan, P. Turcano, C. Stang, E. Camerucci, C. Piat, J. Bower, R. Savica (Rochester, USA)

    Objective: To assess the usage frequency of dopamine agonists (DA), the prevalence of impulse control disorder (ICD) in patients with Early-onset Parkinson’s Disease (EOPD), and…
  • 2023 International Congress

    Preoperative motor deficits and depressive symptoms predict quality of life in patients with Parkinson’s disease at different time points after surgery for subthalamic stimulation.

    C. Semmler (Cologne, Germany)

    Objective: This retrospective study explored whether preoperative motor, cognitive, and affective parameters predict QoL and QoL components at 6 and 12 months after STN-DBS surgery.…
  • 2023 International Congress

    The characterization of Parkinson’s disease related nociplastic pain based on the classification system

    T. Tezuka, T. Nukariya, S. Okusa, Y. Nihei, J. Nakahara, M. Seki (Tokyo, Japan)

    Objective: The characteristics of Parkinson’s disease (PD)-related nociplastic pain were evaluated by using various indicators including PD pain classification system (PD-PCS), King's Parkinson Disease Pain…
  • 2023 International Congress

    SYNCHRONIZE: Real-world retrospective safety analysis in patients treated with onabotulinumtoxinA for more than one therapeutic indication

    A. Patel, G. Forde, K. Martinez, A. Mayadev, B. Brucker, K. Becker Ifantides, R. Singh, M. Nelson, I. Yushmanova, S. Battucci, C. Rhyne (Overland Park, USA)

    Objective: Report real-world safety of onabotulinumtoxinA used concomitantly for multiple therapeutic indications. Background: Therapeutic onabotulinumtoxinA is approved in the US for 12 indications, some of…
  • « Previous Page
  • 1
  • …
  • 231
  • 232
  • 233
  • 234
  • 235
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • An atypical and interesting feature of Parkinson´s disease
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley